TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Spire Healthcare ( (GB:SPI) ) has issued an update.
Spire Healthcare Group PLC announced the successful passage of all resolutions at its 2025 Annual General Meeting, held on May 14, 2025. The results indicate strong shareholder support, with most resolutions receiving near-unanimous approval. This outcome reflects positively on the company’s governance and may enhance its position in the healthcare sector, potentially influencing investor confidence and future strategic decisions.
The most recent analyst rating on (GB:SPI) stock is a Buy with a £321.00 price target. To see the full list of analyst forecasts on Spire Healthcare stock, see the GB:SPI Stock Forecast page.
Spark’s Take on GB:SPI Stock
According to Spark, TipRanks’ AI Analyst, GB:SPI is a Neutral.
Spire Healthcare’s overall stock score reflects strong revenue growth and strategic corporate initiatives, tempered by modest net profitability and high leverage. While technical indicators are mixed, the company’s strategic NHS partnership and recent acquisitions offer a positive outlook. However, valuation concerns suggest the stock may be overvalued, warranting cautious optimism.
To see Spark’s full report on GB:SPI stock, click here.
More about Spire Healthcare
Spire Healthcare Group PLC operates in the healthcare industry, providing a range of medical services including private hospital care, diagnostics, and outpatient services. The company focuses on delivering high-quality healthcare solutions across the UK, catering to both private patients and those referred by the National Health Service (NHS).
Average Trading Volume: 954,151
Technical Sentiment Signal: Sell
Current Market Cap: £792.7M
For detailed information about SPI stock, go to TipRanks’ Stock Analysis page.